Related Experiment Video
Updated: Jun 26, 2026

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
Published on: March 7, 2017
Paediatric extracranial germ-cell tumours.
Furqan Shaikh1, Matthew J Murray2, James F Amatruda3
1Division of Haematology and Oncology, The Hospital for Sick Children and the University of Toronto, Toronto, ON, Canada.
Managing paediatric extracranial germ-cell tumours presents unique challenges due to their heterogeneity. Improving outcomes requires better risk stratification, biomarkers, and international collaboration for all patients.
Area of Science:
- Oncology
- Paediatric Medicine
- Cancer Research
Background:
- Paediatric extracranial germ-cell tumours are a diverse group of neoplasms with varied presentations and behaviors.
- Management is complex due to differences between paediatric, adolescent, and adult disease, requiring specialized care.
- Current treatment approaches have evolved disparately, leading to suboptimal outcomes for certain patient groups.
Purpose of the Study:
- To highlight the unique challenges in managing paediatric extracranial germ-cell tumours.
- To identify patient groups with suboptimal outcomes and significant long-term toxicities.
- To outline future directions for improving patient care and outcomes through research and collaboration.
Main Methods:
- This study is a review and synthesis of current knowledge on paediatric extracranial germ-cell tumours.
- It analyzes the complexities in staging, risk stratification, and treatment.
- It discusses the impact of molecular studies and collaborative clinical data.
Main Results:
- Suboptimal outcomes persist for adolescents, extragonadal tumours, high tumour markers, and platinum-resistant disease.
- Survivors experience significant long-term toxicities.
- Current management strategies face challenges in providing age-appropriate, evidence-based care.
Conclusions:
- Future research must focus on translating molecular insights and collaborative data into improved patient outcomes.
- Enhanced risk-stratification systems and biomarkers for response and toxicity are crucial.
- International collaboration and novel therapeutic approaches are needed for poor-risk patients.
More Related Videos
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
07:44Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025